Dubai Telegraph - Once-taboo ketamine booms for US at-home mental care

EUR -
AED 3.84909
AFN 70.983076
ALL 98.168084
AMD 408.033489
ANG 1.877746
AOA 956.772304
ARS 1045.934567
AUD 1.608014
AWG 1.888917
AZN 1.780997
BAM 1.956142
BBD 2.103608
BDT 124.501747
BGN 1.96788
BHD 0.392672
BIF 3077.56693
BMD 1.047943
BND 1.404259
BOB 7.239401
BRL 6.098928
BSD 1.041892
BTN 88.430422
BWP 14.233758
BYN 3.409661
BYR 20539.683689
BZD 2.100107
CAD 1.461529
CDF 3008.644792
CHF 0.933707
CLF 0.036935
CLP 1019.137039
CNY 7.592031
CNH 7.595984
COP 4600.207983
CRC 530.697762
CUC 1.047943
CUP 27.770491
CVE 110.899218
CZK 25.334232
DJF 185.535949
DKK 7.457456
DOP 62.791567
DZD 139.877767
EGP 51.749446
ERN 15.719146
ETB 127.546696
FJD 2.385066
FKP 0.827159
GBP 0.83215
GEL 2.871065
GGP 0.827159
GHS 16.552662
GIP 0.827159
GMD 74.404001
GNF 8980.654359
GTQ 8.08725
GYD 219.183481
HKD 8.154967
HNL 26.32885
HRK 7.475249
HTG 136.765194
HUF 411.595345
IDR 16624.306486
ILS 3.879155
IMP 0.827159
INR 88.307488
IQD 1364.864451
IRR 44092.203499
ISK 146.344923
JEP 0.827159
JMD 165.980576
JOD 0.743093
JPY 161.794551
KES 135.676997
KGS 90.649326
KHR 4194.772734
KMF 495.143365
KPW 943.148344
KRW 1467.769713
KWD 0.322609
KYD 0.868268
KZT 520.220796
LAK 22885.434193
LBP 93300.07746
LKR 303.238754
LRD 189.101446
LSL 18.801143
LTL 3.094303
LVL 0.63389
LYD 5.087986
MAD 10.539574
MDL 19.003682
MGA 4862.942225
MKD 61.540749
MMK 3403.678134
MNT 3560.910412
MOP 8.353519
MRU 41.455637
MUR 49.074871
MVR 16.201526
MWK 1806.650049
MXN 21.359806
MYR 4.668554
MZN 66.973635
NAD 18.801143
NGN 1769.410365
NIO 38.337062
NOK 11.559514
NPR 140.70592
NZD 1.790636
OMR 0.401068
PAB 1.047692
PEN 3.95069
PGK 4.194773
PHP 61.7584
PKR 289.326398
PLN 4.334357
PYG 8133.57593
QAR 3.820851
RON 4.978251
RSD 117.724856
RUB 108.694151
RWF 1422.262
SAR 3.934395
SBD 8.785488
SCR 14.270629
SDG 630.340687
SEK 11.508746
SGD 1.410154
SHP 0.827159
SLE 23.819809
SLL 21974.846653
SOS 595.409683
SRD 37.195668
STD 21690.30525
SVC 9.116766
SYP 2632.988191
SZL 18.794642
THB 36.22582
TJS 11.157609
TMT 3.667801
TND 3.328435
TOP 2.454385
TRY 36.218374
TTD 7.076236
TWD 34.002924
TZS 2777.049042
UAH 43.103352
UGX 3871.138521
USD 1.047943
UYU 44.554803
UZS 13366.334712
VES 48.817231
VND 26630.85264
VUV 124.413904
WST 2.925428
XAF 656.077858
XAG 0.034259
XAU 0.000393
XCD 2.832119
XDR 0.792554
XOF 656.077858
XPF 119.331742
YER 261.90718
ZAR 18.9268
ZMK 9432.745885
ZMW 28.781577
ZWL 337.437233
  • SCS

    0.2300

    13.27

    +1.73%

  • VOD

    0.1323

    8.73

    +1.52%

  • BCC

    3.4200

    143.78

    +2.38%

  • RIO

    -0.2200

    62.35

    -0.35%

  • RELX

    0.9900

    46.75

    +2.12%

  • CMSD

    0.0150

    24.46

    +0.06%

  • RYCEF

    -0.0100

    6.79

    -0.15%

  • NGG

    1.0296

    63.11

    +1.63%

  • RBGPF

    59.2400

    59.24

    +100%

  • CMSC

    0.0320

    24.672

    +0.13%

  • BCE

    0.0900

    26.77

    +0.34%

  • BTI

    0.4000

    37.38

    +1.07%

  • JRI

    -0.0200

    13.21

    -0.15%

  • GSK

    0.2600

    33.96

    +0.77%

  • AZN

    1.3700

    65.63

    +2.09%

  • BP

    0.2000

    29.72

    +0.67%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

I.Viswanathan--DT